Scientists pinpointed mechanisms associated with severe COVID-19 blood clotting
On Feb. 17, 2022, after studying blood samples from 244 patients hospitalized for COVID-19, a group of researchers,…
On Feb. 17, 2022, after studying blood samples from 244 patients hospitalized for COVID-19, a group of researchers,…
On Jan. 22, 2021, Aurinia Pharmaceuticals announced that the U.S. Food and Drug Administration (FDA)Â had approved LUPKYNISTM…
On Apr. 24, 2020, the U.S. Food and Drug Administration (FDA) issued a Drug Safety Communication regarding known…
On Mar. 19, 2020, Mylan announced it had restarted production of hydroxychloroquine sulfate tablets at its West Virginia…
On May 10, 2004, an international call-to-action has been issued by more than one hundred lupus organizations based…
On Oct. 16, 2003, scientists from the Oklahoma Medical Research Foundation (OMRF) and the University of Oklahoma Health…
On Dec. 15, 1997, scientists from the Oklahoma Medical Research Foundation (OMRF) announced that Systemic Lupus Erythematosus (lupus)…
On Oct. 24, 1988, the first lupus awareness observance which occurred in 1977 was moved to Oct. in…
In 1981, Dr. Morris Reichlin joined the Oklahoma Medical Research Foundation (OMRF) to head the Arthritis and Immunology…
On Aug. 31, 1977, in recognition of the seriousness of lupus and America’s commitment to its control, the…
In 1955, Hydroxychloroquine (HCQ) was approved for medical use in the U.S. in 1955. Chloroquine was discovered in…